Literature DB >> 15544612

Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model.

L Chen1, O Martinez, L Overbergh, C Mathieu, B S Prabhakar, L S Chan.   

Abstract

We investigated cytokine profiles in interleukin (IL)-4 transgenic (Tg) mice with a skin inflammatory disease resembling human atopic dermatitis. cDNA microarray revealed that the mRNAs encoding IL-1beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-13, tumour necrosis factor (TNF)-alpha, TNF-beta and interferon (IFN)-gamma were up-regulated in the skin of late lesion Tg mice and to a lesser degree in non-lesion Tg mice when compared to those of non-Tg mice. Real time reverse transcription-polymerase chain reaction (RT-PCR) analyses indicated that the cDNA copy numbers of IL-1beta, IL-4, IL-6, IL-10, TNF-alpha and IFN-gamma from the skin of late, early and non-lesions increased significantly compared to non-Tg mice. IL-2 and IL-12p40 cDNA copy numbers were increased significantly in early, but not late, lesions. Interestingly, IL-1beta, IL-3, IL-4, IL-5, IL-6, IL-10, IL-13, TNF-alpha, and IFN-gamma cDNAs were increased significantly the skin of before-onset and/or non-lesion mice. Flow cytometry analyses demonstrated an increased percentage of keratinocytes producing IL-4 as the disease progressed. The percentage of IL-2, IL-4, IL-10 and IFN-gamma-producing T cells and IL-12-producing antigen-presenting cells in skin-draining lymph nodes and inflammatory skin also increased, particularly in mice with late lesion. These results suggest that disease induction is primarily triggered by Th2 cytokines and that Th1, Th2 and non-Th proinflammatory cytokines are all involved in the disease process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15544612      PMCID: PMC1809236          DOI: 10.1111/j.1365-2249.2004.02649.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  56 in total

Review 1.  Cytokines, chaos, and complexity.

Authors:  R Callard; A J George; J Stark
Journal:  Immunity       Date:  1999-11       Impact factor: 31.745

2.  T cells in atopic dermatitis.

Authors:  K D Cooper; S R Stevens
Journal:  J Am Acad Dermatol       Date:  2001-07       Impact factor: 11.527

Review 3.  Keratins and the keratinocyte activation cycle.

Authors:  I M Freedberg; M Tomic-Canic; M Komine; M Blumenberg
Journal:  J Invest Dermatol       Date:  2001-05       Impact factor: 8.551

Review 4.  Langerhans cell migration.

Authors:  M Cumberbatch; R J Dearman; C E Griffiths; I Kimber
Journal:  Clin Exp Dermatol       Date:  2000-07       Impact factor: 3.470

5.  CCL27-CCR10 interactions regulate T cell-mediated skin inflammation.

Authors:  Bernhard Homey; Harri Alenius; Anja Müller; Hortensia Soto; Edward P Bowman; Wei Yuan; Leslie McEvoy; Antti I Lauerma; Till Assmann; Erich Bünemann; Maili Lehto; Henrik Wolff; David Yen; Heather Marxhausen; Wayne To; Jonathon Sedgwick; Thomas Ruzicka; Percy Lehmann; Albert Zlotnik
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

Review 6.  Interleukin-3 and stress.

Authors:  H Bessler; M Bergman; H Salman
Journal:  Biomed Pharmacother       Date:  2000-07       Impact factor: 6.529

7.  Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions.

Authors:  C Vestergaard; H Yoneyama; M Murai; K Nakamura; K Tamaki; Y Terashima; T Imai; O Yoshie; T Irimura; H Mizutani; K Matsushima
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

8.  Enrichment for murine keratinocyte stem cells based on cell surface phenotype.

Authors:  H Tani; R J Morris; P Kaur
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

9.  Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis.

Authors:  L S Chan; N Robinson; L Xu
Journal:  J Invest Dermatol       Date:  2001-10       Impact factor: 8.551

10.  Assessment of preferential Th1 or Th2 induction by low-molecular-weight compounds using a reverse transcription-polymerase chain reaction method: comparison of two mouse strains, C57BL/6 and BALB/c.

Authors:  M Hayashi; K Higashi; H Kato; H Kaneko
Journal:  Toxicol Appl Pharmacol       Date:  2001-11-15       Impact factor: 4.219

View more
  40 in total

1.  Therapeutic effects of recombinant Salmonella typhimurium harboring CCL22 miRNA on atopic dermatitis-like skin in mice.

Authors:  Won Suck Yoon; Seung Seok Lee; Yang Seok Chae; Yong Keun Park
Journal:  Exp Mol Med       Date:  2011-02-28       Impact factor: 8.718

Review 2.  Lessons from murine models of atopic dermatitis.

Authors:  Tao Zheng; Zhou Zhu
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.806

3.  Interleukin-4 Downregulation of Involucrin Expression in Human Epidermal Keratinocytes Involves Stat6 Sequestration of the Coactivator CREB-Binding Protein.

Authors:  Lei Bao; Jaime B Alexander; Huayi Zhang; Kui Shen; Lawrence S Chan
Journal:  J Interferon Cytokine Res       Date:  2016-02-26       Impact factor: 2.607

Review 4.  T-cell positioning by chemokines in autoimmune skin diseases.

Authors:  Jillian M Richmond; James P Strassner; Kingsley I Essien; John E Harris
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

Review 5.  Allergic Contact Dermatitis Evaluation: Strategies for the Preschooler.

Authors:  Calvin T Sung; Maria A McGowan; Sharon E Jacob
Journal:  Curr Allergy Asthma Rep       Date:  2018-08-01       Impact factor: 4.806

6.  Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis.

Authors:  Lin Chen; O Martinez; P Venkataramani; S-X Lin; B S Prabhakar; L S Chan
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

7.  The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE.

Authors:  L Chen; S-X Lin; L Overbergh; C Mathieu; L S Chan
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 8.  Cellular and molecular mechanisms of TSLP function in human allergic disorders--TSLP programs the "Th2 code" in dendritic cells.

Authors:  Tomoki Ito; Yong-Jun Liu; Kazuhiko Arima
Journal:  Allergol Int       Date:  2011-12-25       Impact factor: 5.836

Review 9.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

10.  VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model.

Authors:  Lin Chen; Shao-xia Lin; Sanober Amin; Lut Overbergh; Giacomo Maggiolino; Lawrence S Chan
Journal:  Immunol Cell Biol       Date:  2010-01-12       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.